BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22189395)

  • 21. Review of the molecular genetics and chemotherapeutic treatment of adult and paediatric medulloblastoma.
    Newton HB
    Expert Opin Investig Drugs; 2001 Dec; 10(12):2089-104. PubMed ID: 11772307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.
    Ellison DW; Kocak M; Dalton J; Megahed H; Lusher ME; Ryan SL; Zhao W; Nicholson SL; Taylor RE; Bailey S; Clifford SC
    J Clin Oncol; 2011 Apr; 29(11):1400-7. PubMed ID: 20921458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childhood medulloblastoma: the paradigm shift in molecular stratification and treatment profile.
    Sadighi Z; Vats T; Khatua S
    J Child Neurol; 2012 Oct; 27(10):1302-7. PubMed ID: 22826514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissecting the genomic complexity underlying medulloblastoma.
    Jones DT; Jäger N; Kool M; Zichner T; Hutter B; Sultan M; Cho YJ; Pugh TJ; Hovestadt V; Stütz AM; Rausch T; Warnatz HJ; Ryzhova M; Bender S; Sturm D; Pleier S; Cin H; Pfaff E; Sieber L; Wittmann A; Remke M; Witt H; Hutter S; Tzaridis T; Weischenfeldt J; Raeder B; Avci M; Amstislavskiy V; Zapatka M; Weber UD; Wang Q; Lasitschka B; Bartholomae CC; Schmidt M; von Kalle C; Ast V; Lawerenz C; Eils J; Kabbe R; Benes V; van Sluis P; Koster J; Volckmann R; Shih D; Betts MJ; Russell RB; Coco S; Tonini GP; Schüller U; Hans V; Graf N; Kim YJ; Monoranu C; Roggendorf W; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; von Deimling A; Witt O; Maass E; Rössler J; Ebinger M; Schuhmann MU; Frühwald MC; Hasselblatt M; Jabado N; Rutkowski S; von Bueren AO; Williamson D; Clifford SC; McCabe MG; Collins VP; Wolf S; Wiemann S; Lehrach H; Brors B; Scheurlen W; Felsberg J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo ML; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P
    Nature; 2012 Aug; 488(7409):100-5. PubMed ID: 22832583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children.
    Triscott J; Lee C; Foster C; Manoranjan B; Pambid MR; Berns R; Fotovati A; Venugopal C; O'Halloran K; Narendran A; Hawkins C; Ramaswamy V; Bouffet E; Taylor MD; Singhal A; Hukin J; Rassekh R; Yip S; Northcott P; Singh SK; Dunham C; Dunn SE
    Cancer Res; 2013 Nov; 73(22):6734-44. PubMed ID: 24019381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are molecular subgroups of medulloblastomas really prognostic?
    Frappaz D; Faure-Conter C; Meyronet D; Levard-Bonneville A; Beuriat PA; Sunyach MP; Barritault M
    Curr Opin Neurol; 2018 Dec; 31(6):747-751. PubMed ID: 30300240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
    Ramaswamy V; Remke M; Bouffet E; Bailey S; Clifford SC; Doz F; Kool M; Dufour C; Vassal G; Milde T; Witt O; von Hoff K; Pietsch T; Northcott PA; Gajjar A; Robinson GW; Padovani L; André N; Massimino M; Pizer B; Packer R; Rutkowski S; Pfister SM; Taylor MD; Pomeroy SL
    Acta Neuropathol; 2016 Jun; 131(6):821-31. PubMed ID: 27040285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult medulloblastoma comprises three major molecular variants.
    Remke M; Hielscher T; Northcott PA; Witt H; Ryzhova M; Wittmann A; Benner A; von Deimling A; Scheurlen W; Perry A; Croul S; Kulozik AE; Lichter P; Taylor MD; Pfister SM; Korshunov A
    J Clin Oncol; 2011 Jul; 29(19):2717-23. PubMed ID: 21632505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.
    Gottardo NG; Hansford JR; McGlade JP; Alvaro F; Ashley DM; Bailey S; Baker DL; Bourdeaut F; Cho YJ; Clay M; Clifford SC; Cohn RJ; Cole CH; Dallas PB; Downie P; Doz F; Ellison DW; Endersby R; Fisher PG; Hassall T; Heath JA; Hii HL; Jones DT; Junckerstorff R; Kellie S; Kool M; Kotecha RS; Lichter P; Laughton SJ; Lee S; McCowage G; Northcott PA; Olson JM; Packer RJ; Pfister SM; Pietsch T; Pizer B; Pomeroy SL; Remke M; Robinson GW; Rutkowski S; Schoep T; Shelat AA; Stewart CF; Sullivan M; Taylor MD; Wainwright B; Walwyn T; Weiss WA; Williamson D; Gajjar A
    Acta Neuropathol; 2014 Feb; 127(2):189-201. PubMed ID: 24264598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of tumor location on subtypes of medulloblastoma.
    Teo WY; Shen J; Su JM; Yu A; Wang J; Chow WY; Li X; Jones J; Dauser R; Whitehead W; Adesina AM; Chintagumpala M; Man TK; Lau CC
    Pediatr Blood Cancer; 2013 Sep; 60(9):1408-10. PubMed ID: 23512859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma.
    Huse JT; Holland EC
    Nat Rev Cancer; 2010 May; 10(5):319-31. PubMed ID: 20414201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular genetics of medulloblastoma: an assessment of new therapeutic targets.
    Carlotti CG; Smith C; Rutka JT
    Neurosurg Rev; 2008 Oct; 31(4):359-68; discussion 368-9. PubMed ID: 18548301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medulloblastoma molecular dissection: the way toward targeted therapy.
    Remke M; Ramaswamy V; Taylor MD
    Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medulloblastoma development: tumor biology informs treatment decisions.
    Gopalakrishnan V; Tao RH; Dobson T; Brugmann W; Khatua S
    CNS Oncol; 2015; 4(2):79-89. PubMed ID: 25768332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Notch signaling and natural killer cell infiltration in tumor tissues underlie medulloblastoma prognosis.
    Liang KH; Chang CC; Wu KS; Yu AL; Sung SY; Lee YY; Liang ML; Chen HH; Fen JJ; Chao ME; Liao YT; Wong TT
    Sci Rep; 2021 Dec; 11(1):23282. PubMed ID: 34857809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic Insights.
    Khatua S; Song A; Citla Sridhar D; Mack SC
    Curr Neuropharmacol; 2018; 16(7):1045-1058. PubMed ID: 29189165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA profiling of pediatric Medulloblastoma.
    Kesherwani V; Shukla M; Coulter DW; Sharp JG; Joshi SS; Chaturvedi NK
    BMC Med Genomics; 2020 Jun; 13(1):87. PubMed ID: 32591022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intertumoral Heterogeneity within Medulloblastoma Subgroups.
    Cavalli FMG; Remke M; Rampasek L; Peacock J; Shih DJH; Luu B; Garzia L; Torchia J; Nor C; Morrissy AS; Agnihotri S; Thompson YY; Kuzan-Fischer CM; Farooq H; Isaev K; Daniels C; Cho BK; Kim SK; Wang KC; Lee JY; Grajkowska WA; Perek-Polnik M; Vasiljevic A; Faure-Conter C; Jouvet A; Giannini C; Nageswara Rao AA; Li KKW; Ng HK; Eberhart CG; Pollack IF; Hamilton RL; Gillespie GY; Olson JM; Leary S; Weiss WA; Lach B; Chambless LB; Thompson RC; Cooper MK; Vibhakar R; Hauser P; van Veelen MC; Kros JM; French PJ; Ra YS; Kumabe T; López-Aguilar E; Zitterbart K; Sterba J; Finocchiaro G; Massimino M; Van Meir EG; Osuka S; Shofuda T; Klekner A; Zollo M; Leonard JR; Rubin JB; Jabado N; Albrecht S; Mora J; Van Meter TE; Jung S; Moore AS; Hallahan AR; Chan JA; Tirapelli DPC; Carlotti CG; Fouladi M; Pimentel J; Faria CC; Saad AG; Massimi L; Liau LM; Wheeler H; Nakamura H; Elbabaa SK; Perezpeña-Diazconti M; Chico Ponce de León F; Robinson S; Zapotocky M; Lassaletta A; Huang A; Hawkins CE; Tabori U; Bouffet E; Bartels U; Dirks PB; Rutka JT; Bader GD; Reimand J; Goldenberg A; Ramaswamy V; Taylor MD
    Cancer Cell; 2017 Jun; 31(6):737-754.e6. PubMed ID: 28609654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of GNAS, TP53, and PTEN Improves the Patient Prognostication in Sonic Hedgehog (SHH) Medulloblastoma Subgroup.
    da Silva LS; Mançano BM; de Paula FE; Dos Reis MB; de Almeida GC; Matsushita M; Junior CA; Evangelista AF; Saggioro F; Serafini LN; Stavale JN; Malheiros SMF; Lima M; Hajj GNM; de Lima MA; Taylor MD; Leal LF; Reis RM
    J Mol Diagn; 2020 Jul; 22(7):957-966. PubMed ID: 32380172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.